Trial Profile
A retrospective, pre-post cohort, observational study of Omalizumab in patients with persistent asthma followed in Canadian Clinical Settings
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2017
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 11 Jul 2017 New trial record
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society